ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

IMNM Immunome Inc

15,21
0,06 (0,40%)
07 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Immunome Inc IMNM NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,06 0,40% 15,21 18:57:13
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
14,93 14,93 15,355 15,20 15,15
mais cotações »

Notícias Recentes

Data Hora Fonte Título
20/05/202409:00BWImmunome Announces Completion of Purchase of Assets from..
17/05/202409:00BWImmunome Announces Promotion of Max Rosett to Chief..
14/05/202409:00BWImmunome Reports First Quarter 2024 Financial Results and..
08/05/202409:00BWImmunome to Present at 2024 Bank of America Healthcare..
02/05/202409:00BWImmunome Appoints Kinney Horn as Chief Business Officer
25/04/202409:26BWImmunome Appoints Sandra M. Swain to Board of Directors
05/04/202409:00BWImmunome to Present Preclinical Data for IM-3050, Its Lead..
28/03/202417:02BWImmunome Reports Full Year 2023 Financial Results and..
26/03/202409:00BWImmunome Completes Acquisition of AL102, a Phase 3 Asset for..
07/03/202410:00BWImmunome to Participate in the Leerink Partners Global..
01/03/202410:00BWImmunome to Participate in the TD Cowen 44th Annual..
20/02/202410:15BWImmunome Recognizes Ayala Pharmaceuticals’ Announced..
16/02/202418:05BWImmunome Announces Closing of Public Offering and Full..
14/02/202400:38BWImmunome Announces Pricing of Public Offering of Common..
13/02/202418:05BWImmunome Announces Proposed Public Offering of Common Stock
05/02/202410:00BWImmunome to Present at the Guggenheim Healthcare Talks 6th..
08/01/202409:00BWImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug..
04/01/202410:00BWImmunome Appoints Phil Roberts as Chief Technical Officer
03/01/202410:00BWImmunome to Present at the 42nd Annual J.P. Morgan..
02/01/202410:00BWImmunome Appoints Carol A. Schafer to Board of Directors
26/12/202310:30GLOBEAtreca Announces Asset Purchase Agreement for Sale of..
10/11/202310:00BWImmunome to Present at the Stifel 2023 Healthcare Conference
09/11/202310:00BWImmunome Reports Third Quarter 2023 Financial Results
08/11/202310:00BWImmunome Appoints Jean-Jacques Bienaimé to Board of..
19/10/202309:00BWImmunome Appoints Bob Lechleider, M.D., as Chief Medical..
03/10/202309:00BWImmunome and Morphimmune Announce Successful Completion of..
09/08/202309:00BWImmunome Reports Second Quarter 2023 Financial Results
29/06/202310:00PRNUSImmunome and Morphimmune Announce Definitive Merger..

Seu Histórico Recente

Delayed Upgrade Clock